Joy Wan

Joy Wan

Auto-generated profile, based on publicly available information

Joy Wan

Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2023 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
JWJoy Wan
Joy Wan
DSDaniel B Shin
Daniel B Shin
MSMaha N Syed
Maha N Syed
KAKatrina Abuabara
Katrina Abuabara
ALAdina R Lemeshow
Adina R Lemeshow
JGJoel M Gelfand
Joel M Gelfand
Atopic dermatitis (AD) is associated with immunological dysfunction, which may influence cancer development. Previous studies of AD and cancer demonstrate inconsistent results and few of these studies examined children or AD severity and treatment. To determine malignancy risk among children and adults with AD. We conducted a cohort study using electronic health records data from UK general practices in The Health Improvement Network between 1994 and 2015. Children (< 18 years old) and adults (≥ 18 years old) with AD were matched on age, practice and index date to patients without AD. AD was categorized as mild, moderate or severe using treatments and dermatology referrals as proxies. The primary outcome was any incident malignancy, including in situ malignancy, identified using diagnosis codes and categorized into haematological, skin and solid organ malignancies. Secondary outcomes included specific malignancies: leukaemia, lymphoma, melanoma, nonmelanoma skin cancer (NMSC) and common solid-organ cancers. Among 409 431 children with AD (93.2% mild, 5.5% moderate, 1.3% severe) and 1 809 029 children without AD who had median follow-up of 5–7 years, the incidence rates of malignancy were 1.9–3.4 and 2.0 per 10 000 person-years (PY), respectively. The adjusted risk of malignancy overall did not differ with respect to AD [hazard ratio (HR) 1.02 (95% confidence interval 0.92–1.12)]. Severe AD was associated with increased lymphoma risk [HR 3.18 (1.41–7.16), excluding cutaneous T-cell lymphoma (CTCL)], and mild AD was associated with increased NMSC risk [1.55 (1.06–2.27)]. Among 625 083 adults with AD (65.7% mild, 31.4% moderate, 2.9% severe) and 2 678 888 adults without AD who had median follow-up of 5 years, incidence rates of malignancy were 97.4–125.3 per 10 000 PY and 103.7 per 10 000 PY, respectively. The adjusted risk of any malignancy did not differ with respect to AD [HR 1.00 (0.99–1.02)]. However, adults with severe AD had a twofold higher risk of non-CTCL lymphoma. AD was also associated with slightly higher skin cancer risk [HR 1.06 (1.04–1.08)] and slightly lower solid cancer risk [0.97 (0.96–0.98)] but results varied by specific cancers and AD severity. Epidemiological evidence does not support a strong overall malignancy risk in AD but lymphoma risk may be increased with severe AD.

1 June 2020 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
JWJoy Wan
Joy Wan
JTJunko Takeshita
Junko Takeshita
DSDaniel B. Shin
Daniel B. Shin
JGJoel M. Gelfand
Joel M. Gelfand

1 September 2019 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JWJoy Wan
Joy Wan
AOArman Oganisian
Arman Oganisian
ASAndrew J. Spieker
Andrew J. Spieker
OHOle J. Hoffstad
Ole J. Hoffstad
NMNandita Mitra
Nandita Mitra
JTJunko Takeshita
Junko Takeshita

20 January 2022 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JWJ. Wan
J. Wan
DSD.B. Shin
D.B. Shin
MSM.N. Syed
M.N. Syed
KAK. Abuabara
K. Abuabara
ALA.R. Lemeshow
A.R. Lemeshow
JGJ.M. Gelfand
J.M. Gelfand

8 September 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
JWJoy Wan
Joy Wan
DSDaniel B. Shin
Daniel B. Shin
MSMaha N. Syed
Maha N. Syed
KAKatrina Abuabara
Katrina Abuabara
ALAdina R. Lemeshow
Adina R. Lemeshow
JGJoel M. Gelfand
Joel M. Gelfand

1 December 2019 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
JWJoy Wan
Joy Wan
NMNandita Mitra
Nandita Mitra
OHOle J. Hoffstad
Ole J. Hoffstad
AYAlbert C. Yan
Albert C. Yan
DMDavid J. Margolis
David J. Margolis